{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:36:58Z","timestamp":1648712218346},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s13730-012-0034-1","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T07:55:43Z","timestamp":1349337343000},"page":"34-37","source":"Crossref","is-referenced-by-count":0,"title":["Atypical hemolytic uremic syndrome with MCP mutations preceded by respiratory infection"],"prefix":"10.1007","volume":"2","author":[{"given":"Keiko","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bresin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"34_CR1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Eng J Med. 2009;361:1676\u201387.","journal-title":"N Eng J Med"},{"key":"34_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","volume":"24","author":"G Ariceta","year":"2009","unstructured":"Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Loirat C, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009;24:687\u201396.","journal-title":"Pediatr Nephrol"},{"key":"34_CR3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00467-009-1188-8","volume":"24","author":"JC Davin","year":"2009","unstructured":"Davin JC, Buter N, Groothoff J, van Wijk J, Bouts A, Strain L, et al. Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome. Pediatr Nephrol. 2009;24:1757\u201360.","journal-title":"Pediatr Nephrol"},{"key":"34_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10157-010-0375-z","volume":"15","author":"E Matsukuma","year":"2011","unstructured":"Matsukuma E, Gotoh Y, Kuroyanagi Y, Yamada T, Iwasa M, Yamakawa S, et al. A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations. Clin Exp Nephrol. 2011;15:269\u201374.","journal-title":"Clin Exp Nephrol"},{"key":"34_CR5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Battinaglio P, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006;108:1267\u201379.","journal-title":"Blood"},{"key":"34_CR6","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007;18:2392\u2013400.","journal-title":"J Am Soc Nephrol"},{"key":"34_CR7","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1681\/ASN.2005101051","volume":"17","author":"V Fremeaux-Bacchi","year":"2006","unstructured":"Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2006;17:2015\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"34_CR8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:1035\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1681\/ASN.V961126","volume":"9","author":"BS Kaplan","year":"1998","unstructured":"Kaplan BS, Meyers KE, Schulman SL. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol. 1998;9:1126\u201333.","journal-title":"J Am Soc Nephrol"},{"key":"34_CR10","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"AR Constantinescu","year":"2008","unstructured":"Constantinescu AR, Bitzan M, Weiss LE, Christen E, Kaplan BS, Cnaan A, et al. Non-enteropathic hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008;23:1749\u201360.","journal-title":"Pediatr Nephrol"},{"key":"34_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423\u201331.","journal-title":"Kidney Int"},{"key":"34_CR12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60:831\u201346.","journal-title":"Kidney Int"},{"key":"34_CR13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-2005-925474","volume":"31","author":"A Zakarija","year":"2005","unstructured":"Zakarija A, Bennett C. Drug-indused thrombotic microangiopathy. Semin Thromb Hemost. 2005;31:681\u201390.","journal-title":"Semin Thromb Hemost"},{"key":"34_CR14","doi-asserted-by":"crossref","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5:1844\u201359.","DOI":"10.2215\/CJN.02210310"},{"key":"34_CR15","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007;18:2392\u2013400.","journal-title":"J Am Soc Nephrol"},{"key":"34_CR16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/j.1537-2995.2007.01405.x","volume":"47","author":"B Michon","year":"2007","unstructured":"Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, et al. Complications of apheresis in children. Transfusion. 2007;47:1837\u201342.","journal-title":"Transfusion"},{"key":"34_CR17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","volume":"360","author":"RA Gruppo","year":"2009","unstructured":"Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360:544\u20136.","journal-title":"N Engl J Med"},{"key":"34_CR18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","volume":"360","author":"J N\u00fcrnberger","year":"2009","unstructured":"N\u00fcrnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360:542\u20134.","journal-title":"N Engl J Med"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-012-0034-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-012-0034-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-012-0034-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T23:50:42Z","timestamp":1643500242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-012-0034-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s13730-012-0034-1","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]}}}